Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4GP
|
||||
Former ID |
DNC010415
|
||||
Drug Name |
Propan-2-one O-4-(nonyloxy)phenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H30N2O3
|
||||
Canonical SMILES |
CCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
|
||||
InChI |
1S/C19H30N2O3/c1-4-5-6-7-8-9-10-15-23-18-13-11-17(12-14-18)20-19(22)24-21-16(2)3/h11-14H,4-10,15H2,1-3H3,(H,20,22)
|
||||
InChIKey |
JNUCPQPMMFLJDL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.